To evaluate the Safety and efficacy of Unani formulations in the treatment of Anorexia

Clinical Validation of Unani Pharmacopoeial formulation Jawarish Ood Shireen in Zof al-IshtihÄ? (Anorexia)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/02/005591

Enrollment

300

Registered

2015-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R630- Anorexia Health Condition 2: null- Zof al-IshtihÄ? (Anorexia)

Interventions

Intervention1: Jawarish Ood Shireen: Jawarish Ood Shireen, 5 gm Orally, BD with water before meals for a period of two weeks Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: •Patients of either sex in the age group of 18-65 •Decreased Appetite with SNAQ

Exclusion criteria

Exclusion criteria: •Patients having Anorexia nervosa •Patients with disorders requiring long term treatment •Known cases of Hepatic, Renal or Cardiac Ailments •History of addictions (Alcohol, Drugs) •Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptomsTimepoint: 2 weeks	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 2 weeks	—

Countries

India

Contacts

Public Contactdr pradeep kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026